87 related articles for article (PubMed ID: 24511009)
1. The significance of HSP90AA1, HSP90AB1 and HSP90B1 gene polymorphisms in a Turkish population with non-small cell lung cancer.
Coskunpinar E; Akkaya N; Yildiz P; Oltulu YM; Aynaci E; Isbir T; Yaylim I
Anticancer Res; 2014 Feb; 34(2):753-7. PubMed ID: 24511009
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
3. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.
Rafrafi A; Chahed B; Kaabachi S; Kaabachi W; Maalmi H; Hamzaoui K; Sassi FH
Hum Immunol; 2013 Oct; 74(10):1368-74. PubMed ID: 23831257
[TBL] [Abstract][Full Text] [Related]
4. Basic characterization of 90 kDa heat shock protein genes HSP90AA1, HSP90AB1, HSP90B1 and TRAP1 expressed in Japanese quail (Coturnix japonica).
Nagahori K; Iwamoto S; Maruyama A; Suzuki S; Hosomichi K; Shiina T; Hara H; Yoshida Y; Hanzawa K
Anim Sci J; 2010 Aug; 81(4):513-8. PubMed ID: 20662823
[TBL] [Abstract][Full Text] [Related]
5. Relationship between genetic polymorphisms of DNA ligase 1 and non-small cell lung cancer susceptibility and radiosensitivity.
Tian H; He X; Yin L; Guo WJ; Xia YY; Jiang ZX
Genet Mol Res; 2015 Jun; 14(2):7047-52. PubMed ID: 26125914
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
7. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
9. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
10. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
12. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
14. Protective Role of Genetic Variants in HSP90 Genes-Complex in COPD Secondary to Biomass-Burning Smoke Exposure and Non-Severe COPD Forms in Tobacco Smoking Subjects.
Ambrocio-Ortiz E; Pérez-Rubio G; Ramírez-Venegas A; Hernández-Zenteno RJ; Paredes-López A; Sansores RH; Ramírez-Díaz ME; Cruz-Vicente F; Martínez-Gómez ML; Falfán-Valencia R
Curr Issues Mol Biol; 2021 Aug; 43(2):887-899. PubMed ID: 34449539
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer.
Campa D; Zienolddiny S; Lind H; Ryberg D; Skaug V; Canzian F; Haugen A
Lung Cancer; 2007 Apr; 56(1):17-23. PubMed ID: 17175058
[TBL] [Abstract][Full Text] [Related]
17. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
18. MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancer.
Dogu GG; Kargi A; Turgut S; Ayada C; Taskoylu BY; Demiray G; Yaren A; Ozlu C; Temel S; Ergin A
Gene; 2012 Sep; 506(2):404-7. PubMed ID: 22766400
[TBL] [Abstract][Full Text] [Related]
19. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.
Gomes M; Coelho A; Araújo A; Teixeira AL; Catarino R; Medeiros R
Gene; 2012 Aug; 504(1):111-5. PubMed ID: 22583827
[TBL] [Abstract][Full Text] [Related]
20. STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer.
Jiang B; Zhu ZZ; Liu F; Yang LJ; Zhang WY; Yuan HH; Wang JG; Hu XH; Huang G
Genet Mol Res; 2011 Aug; 10(3):1856-65. PubMed ID: 21948749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
